1,2-distearoyllecithin has been researched along with Hypertension, Pulmonary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alving, CR; Baranyi, L; Basta, M; Bodo, M; Bünger, R; Morse, DS; Savay, S; Stahl, GL; Szebeni, J | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and Hypertension, Pulmonary
Article | Year |
---|---|
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.
Topics: Animals; Antibodies; Cholesterol; Complement Activation; Complement C3a; Complement C5a; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Hypertension, Pulmonary; Immunoglobulins, Intravenous; Infusions, Intravenous; Injections, Intravenous; Linear Models; Liposomes; Male; Particle Size; Phosphatidylcholines; Phosphatidylglycerols; Swine | 2000 |